Partners
CardiNor has secured key technology partnerships to access the expertise and samples needed for assay development.

Bioventix
This LSE-listed company is a global leader in supplying high-quality antibodies to the IVD industry. Serving a prestigious client base that includes Abbott, Roche, Siemens, and bioMérieux, the firm also acts as a strategic investor in CardiNor.
Uniogen
Formerly known as Kaivogen, this Finnish specialist focuses on the development and production of ELISA components and finished kits for the US and European markets. The organization maintains a commitment to excellence, holding ISO 9001:2008 and ISO 13485:2003 quality management certifications via DNV GL.

Akershus University Hospital (AHUS)
As the research hub for Professors Torbjørn Omland and Helge Røsjø—world-leading experts in CVD biomarkers—this institution serves as a key scientific advisor to CardiNor. In collaboration with Stavanger University Hospital, they have provided vital support for the SMASH-1 clinical trial through the collection of blood samples from patients with ICD implants.

Mizar Bio
Originating as the Axis-Shield lab in Bodø, Norway, this partner provides essential support for our assay development. Their scientific team possesses extensive expertise in technology transfer and a proven track record of adapting IVD biomarker assays for proprietary platforms, including Point-of-Care (PoC) instruments.


